Leverage Shares 2X Long Viav Daily ETF (VIAG) closed at $5.47 on November 3, 2026, up 15.2% from the previous close, on volume of 43,129 shares (30-day average 18,323).
Data as of November 3, 2026.
No headlines found.
No press releases found.
No news found.
The Fund is an exchange traded fund ("ETF") that seeks daily leveraged investment results, before fees and expenses, of two times (200%) of the daily percentage change in the price of the common stock of VIAV. The Fund is an actively managed ETF. The Fund invests at least 80% of its net assets (plus borrowings for investment purposes) in the Underlying Security and financial instruments with economic characteristics that, in combination, provide 200% daily leveraged exposure to the price of the Underlying Security, on a daily basis, consistent with the Fund's investment objective. The Fund seeks to achieve its investment objective through the use of derivative instruments, including swap agreements and options contracts, as well as, to a lesser extent, direct investments in the Underlying Security. As part of its investment strategy, the Fund may invest in a combination of standardized exchange-traded and FLexible EXchange ("FLEX") call and put options contracts based on the value of the price returns of the Underlying Security.
Leverage Shares 2X Long Viav Daily ETF trades on the BATS stock market under the symbol VIAG.
As of November 3, 2026, VIAG stock price climbed to $5.47 with 43,129 million shares trading.
VIAG has a market cap of $355,596.00. This is considered a Sub-Micro Cap stock.
VIAG support price is $4.22 and resistance is $5.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VIAG shares will trade within this expected range on the day.
